Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $746M | $903M | $1.09B | $1.17B | $1.04B | $1.17B | $1.11B | $1.66B | $1.56B | $1.48B |
| Revenue growth | — | 21.1% | 21.1% | 7.0% | -11.3% | 13.0% | -5.3% | 49.6% | -6.4% | -5.2% |
| Operating income | -$209M | -$148M | -$99.1M | -$175M | -$112M | $97.7M | -$6.09M | $414M | $421M | $254M |
| Operating margin | -28.0% | -16.4% | -9.1% | -15.0% | -10.8% | 8.3% | -0.5% | 24.9% | 27.0% | 17.2% |
| Net income | -$208M | -$158M | -$139M | -$197M | -$111M | -$48.2M | -$158M | $356M | $367M | $242M |
| Net margin | -28.0% | -17.5% | -12.7% | -16.8% | -10.7% | -4.1% | -14.2% | 21.4% | 23.6% | 16.4% |
| EPS (diluted) | -$1.38 | -$1.03 | -$0.90 | -$1.25 | -$0.70 | -$0.29 | -$0.97 | $2.10 | $2.17 | $1.43 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$63.8M | $19.2M | $99.3M | $72.1M | $82.8M | $102M | $21.0M | $401M | $439M | $521M |
| Capital expenditures | $43.7M | $51.3M | $69.4M | $90.9M | $42.2M | $28.0M | $38.3M | $48.0M | $33.5M | $40.4M |
| Free cash flow | -$107M | -$32.1M | $29.9M | -$18.9M | $40.6M | $73.7M | -$17.2M | $353M | $406M | $480M |
| Share buybacks | — | — | — | — | — | — | — | — | $200M | — |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $186M | $191M | $267M | $204M | $273M | $338M | $292M | $457M | $291M | $389M |
| Total assets | $1.73B | $1.80B | $1.83B | $1.81B | $1.95B | $2.02B | $1.96B | $2.14B | $2.06B | $2.49B |
| Total liabilities | $517M | $594M | $654M | $720M | $883M | $912M | $920M | $934M | $591M | $668M |
| Long-term debt | $281M | $278M | $276M | $274M | $272M | $293M | $290M | $288M | — | — |
| Shareholders' equity | $1.21B | $1.20B | $1.17B | $1.09B | $1.07B | $1.11B | $1.04B | $1.20B | $1.46B | $1.82B |
| Retained earnings | -$948M | -$1.04B | -$1.19B | -$1.38B | -$1.49B | -$1.54B | -$1.70B | -$1.34B | -$976M | -$735M |
| Shares (wtd avg diluted) | 152M | 154M | 156M | 158M | 159M | 165M | 164M | 170M | 169M | 169M |
Every figure is extracted from Alkermes plc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.